Evaluation of the Effect of AVE0657 in Cheynes-Stokes Breathing Syndrome Patients

Summary

The primary objective of this study is to assess the activity on breathing parameters of 4 escalating doses of AVE0657 in comparison to placebo in patients with Cheynes-Stokes Breathing Syndrome.

Timeline

Start

2008-06

Primary completion

2009-03

Completion

2009-03

Outcome

Outcome not reported

Stopped: “Termination following reassessment of the potential benefit-risk of AVE0657”

Drugs

Indications